Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
Orford
J L
JL
Cardiac Catheterization Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kinlay
S
S
Fernandes
J
J
Behrendt
D
D
Ganz
P
P
Selwyn
A P
AP
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006946:Hyperinsulinism / Q000150:complications; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications; D007333:Insulin Resistance; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D007004:Hypoglycemic Agents